CK LIFE SCIENCES INT'L., (HOLDINGS) INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.34 HKD | -2.86% |
|
-10.53% | -45.16% |
| Sales 2021 | 5.4B 690M | Sales 2022 | 5.28B 674M | Capitalization | 7.59B 969M |
|---|---|---|---|---|---|
| Net income 2021 | 163M 20.81M | Net income 2022 | 132M 16.85M | EV / Sales 2021 | 2.3 x |
| Net Debt 2021 | 5.31B 678M | Net Debt 2022 | 5.24B 669M | EV / Sales 2022 | 2.43 x |
| P/E ratio 2021 |
43.8
x | P/E ratio 2022 |
57.5
x | Employees | 1,932 |
| Yield 2021 |
1.35% | Yield 2022 |
1.01% | Free-Float | 25.02% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.86% | ||
| 1 week | -10.53% | ||
| Current month | +1.49% | ||
| 1 month | -15.00% | ||
| 3 months | -42.37% | ||
| 6 months | -50.00% | ||
| Current year | -45.16% |
1 week
0.34
0.40
1 month
0.300.42
Current year
0.300.62
1 year
0.300.82
3 years
0.301.28
5 years
0.301.34
10 years
0.301.34
| Managers | Title | Age | Since |
|---|---|---|---|
Ying Choi Yu
CEO | Chief Executive Officer | 69 | 02-05-31 |
Yiu Leung Mo
DFI | Director of Finance/CFO | 64 | 05-09-30 |
Hing Lam Kam
PSD | President | 78 | 02-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Eva Lee Kwok
BRD | Director/Board Member | 82 | 02-05-31 |
Tzar Kuoi Li
CHM | Chairman | 59 | 02-03-31 |
Hing Lam Kam
PSD | President | 78 | 02-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.97% | 4 M€ | -27.92% | ||
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 0.34 | -2.86% | 2 590 000 |
| 24-04-15 | 0.35 | -4.11% | 4,130,000 |
| 24-04-12 | 0.365 | -6.41% | 6,188,400 |
| 24-04-11 | 0.39 | +2.63% | 8,848,000 |
| 24-04-10 | 0.38 | 0.00% | 8,273,124 |
Delayed Quote Hong Kong S.E., April 16, 2024 at 04:08 am EDT
More quotes
CK Life Sciences Intl (Holdings) Inc is an investment holding company principally engaged in the development and sales of healthcare products. The Company operates through two segments. The Health segment is engaged in the development, production, marketing and sales of healthcare and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others.
Sector
Food Processing
Calendar
2024-07-29
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -45.16% | 430M | |
| +1.89% | 7.34B | |
| -1.66% | 7.14B | |
| +1.75% | 6.03B | |
| -6.34% | 3.75B | |
| -17.05% | 3.17B | |
| -16.35% | 1.15B | |
| +3.72% | 902M | |
| -19.01% | 836M | |
| -46.26% | 828M |
- Stock Market
- Equities
- 775 Stock
